Urgent.News

the world's headlines, one feed

Editions

Finance & Markets

Attovia Therapeutics raises capital in 17 dollar Nasdaq IPO debut

Biopharmaceutical firm Attovia Therapeutics listed on the Nasdaq stock exchange pricing its initial public offering at 17 00 dollars per share to expand clinical development

We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.

Read the original at vir.com.vn →

More in Finance & Markets